- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
GLY.6: 7 residues within 4Å:- Chain A: F.192, Y.235, T.237, F.240
- Chain B: R.98, L.150, S.162
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:S.162, A:T.237
- Salt bridges: B:R.98
GLY.7: 7 residues within 4Å:- Chain A: R.98, L.150, S.162
- Chain E: F.192, Y.235, T.237, F.240
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrogen bonds: E:T.237, A:S.162
- Salt bridges: A:R.98
GLY.17: 7 residues within 4Å:- Chain B: F.192, Y.235, T.237, F.240
- Chain C: R.98, L.150, S.162
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:S.162, B:T.237
- Salt bridges: C:R.98
GLY.27: 7 residues within 4Å:- Chain C: F.192, Y.235, T.237, F.240
- Chain D: R.98, L.150, S.162
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:S.162, C:T.237
- Salt bridges: D:R.98
GLY.37: 7 residues within 4Å:- Chain D: F.192, Y.235, T.237, F.240
- Chain E: R.98, L.150, S.162
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain D- Hydrogen bonds: E:S.162, D:T.237
- Salt bridges: E:R.98
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-functional Binders)(Non-covalent)
PIO.8: 1 residues within 4Å:- Ligands: PIO.10
No protein-ligand interaction detected (PLIP)PIO.9: 2 residues within 4Å:- Chain A: L.257
- Ligands: PIO.50
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.257
PIO.10: 2 residues within 4Å:- Chain A: W.448
- Ligands: PIO.8
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:K.452
PIO.11: 1 residues within 4Å:- Chain A: W.276
No protein-ligand interaction detected (PLIP)PIO.16: 3 residues within 4Å:- Chain A: S.311, V.313
- Ligands: PIO.19
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.313
PIO.18: 1 residues within 4Å:- Ligands: PIO.20
No protein-ligand interaction detected (PLIP)PIO.19: 2 residues within 4Å:- Chain B: L.257
- Ligands: PIO.16
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.257
PIO.20: 2 residues within 4Å:- Chain B: W.448
- Ligands: PIO.18
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.452
PIO.21: 1 residues within 4Å:- Chain B: W.276
No protein-ligand interaction detected (PLIP)PIO.26: 3 residues within 4Å:- Chain B: S.311, V.313
- Ligands: PIO.29
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:V.313
PIO.28: 1 residues within 4Å:- Ligands: PIO.30
No protein-ligand interaction detected (PLIP)PIO.29: 2 residues within 4Å:- Chain C: L.257
- Ligands: PIO.26
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.257
PIO.30: 2 residues within 4Å:- Chain C: W.448
- Ligands: PIO.28
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:K.452
PIO.31: 1 residues within 4Å:- Chain C: W.276
No protein-ligand interaction detected (PLIP)PIO.36: 3 residues within 4Å:- Chain C: S.311, V.313
- Ligands: PIO.39
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:V.313
PIO.38: 1 residues within 4Å:- Ligands: PIO.40
No protein-ligand interaction detected (PLIP)PIO.39: 2 residues within 4Å:- Chain D: L.257
- Ligands: PIO.36
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.257
PIO.40: 2 residues within 4Å:- Chain D: W.448
- Ligands: PIO.38
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:K.452
PIO.41: 1 residues within 4Å:- Chain D: W.276
No protein-ligand interaction detected (PLIP)PIO.46: 3 residues within 4Å:- Chain D: S.311, V.313
- Ligands: PIO.52
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:V.313
PIO.50: 3 residues within 4Å:- Chain E: S.311, V.313
- Ligands: PIO.9
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:V.313
PIO.51: 1 residues within 4Å:- Ligands: PIO.53
No protein-ligand interaction detected (PLIP)PIO.52: 2 residues within 4Å:- Chain E: L.257
- Ligands: PIO.46
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:L.257
PIO.53: 2 residues within 4Å:- Chain E: W.448
- Ligands: PIO.51
1 PLIP interactions:1 interactions with chain E- Salt bridges: E:K.452
PIO.54: 1 residues within 4Å:- Chain E: W.276
No protein-ligand interaction detected (PLIP)- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.12: 2 residues within 4Å:- Chain A: W.276
- Ligands: PX4.48
Ligand excluded by PLIPPX4.13: 3 residues within 4Å:- Chain A: F.446, I.450, Y.451
Ligand excluded by PLIPPX4.14: 3 residues within 4Å:- Chain A: S.329
- Ligands: PX4.15, PX4.22
Ligand excluded by PLIPPX4.15: 3 residues within 4Å:- Chain A: L.325, I.431
- Ligands: PX4.14
Ligand excluded by PLIPPX4.22: 2 residues within 4Å:- Chain B: W.276
- Ligands: PX4.14
Ligand excluded by PLIPPX4.23: 3 residues within 4Å:- Chain B: F.446, I.450, Y.451
Ligand excluded by PLIPPX4.24: 3 residues within 4Å:- Chain B: S.329
- Ligands: PX4.25, PX4.32
Ligand excluded by PLIPPX4.25: 3 residues within 4Å:- Chain B: L.325, I.431
- Ligands: PX4.24
Ligand excluded by PLIPPX4.32: 2 residues within 4Å:- Chain C: W.276
- Ligands: PX4.24
Ligand excluded by PLIPPX4.33: 3 residues within 4Å:- Chain C: F.446, I.450, Y.451
Ligand excluded by PLIPPX4.34: 3 residues within 4Å:- Chain C: S.329
- Ligands: PX4.35, PX4.42
Ligand excluded by PLIPPX4.35: 3 residues within 4Å:- Chain C: L.325, I.431
- Ligands: PX4.34
Ligand excluded by PLIPPX4.42: 2 residues within 4Å:- Chain D: W.276
- Ligands: PX4.34
Ligand excluded by PLIPPX4.43: 3 residues within 4Å:- Chain D: F.446, I.450, Y.451
Ligand excluded by PLIPPX4.44: 3 residues within 4Å:- Chain D: S.329
- Ligands: PX4.45, PX4.55
Ligand excluded by PLIPPX4.45: 3 residues within 4Å:- Chain D: L.325, I.431
- Ligands: PX4.44
Ligand excluded by PLIPPX4.47: 3 residues within 4Å:- Chain E: F.446, I.450, Y.451
Ligand excluded by PLIPPX4.48: 3 residues within 4Å:- Chain E: S.329
- Ligands: PX4.12, PX4.49
Ligand excluded by PLIPPX4.49: 3 residues within 4Å:- Chain E: L.325, I.431
- Ligands: PX4.48
Ligand excluded by PLIPPX4.55: 2 residues within 4Å:- Chain E: W.276
- Ligands: PX4.44
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Homomeric alpha3 glycine receptor in the presence of 1 mM glycine at pH 6.4 in a desensitized state. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-functional Binders)(Non-covalent)
- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Homomeric alpha3 glycine receptor in the presence of 1 mM glycine at pH 6.4 in a desensitized state. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.